Search / Trial NCT06616506

Artificial Intelligence for Highly Myopic Cataract

Launched by SHANGHAI HIGH MYOPIA STUDY GROUP · Sep 25, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

Highly Myopic Cataract Artificial Intelligence Cataract Big Data

ClinConnect Summary

This clinical trial is investigating how artificial intelligence (AI) can help improve the treatment of cataracts in patients with high myopia, which is a condition where people see distant objects as blurry. The goal is to develop an AI model that can more accurately calculate the right type of lens needed for surgery, ensuring better vision outcomes after the procedure.

To participate in this study, individuals must have a specific eye measurement (axial length of 26 mm or more) and be diagnosed with high myopia along with cataracts. Participants will undergo a series of eye examinations before surgery and will need to follow up for at least one month after the procedure to check their healing and vision improvement. This study is currently looking for patients of all ages and genders who meet these criteria and can complete the necessary tests. If you're interested, reach out to the hospital for more information on how to get involved!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital.
  • Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed.
  • If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month.
  • There are no missing clinical data before and after the surgery.
  • Exclusion Criteria:
  • Patients who are unable to cooperate with the required examinations for this study.

Trial Officials

XIANGJIA ZHU

Study Chair

Eye & ENT Hospital of Fudan University

About Shanghai High Myopia Study Group

The Shanghai High Myopia Study Group is a collaborative research consortium dedicated to investigating the epidemiology, etiology, and management of high myopia, a significant public health concern in urban populations. Comprising a multidisciplinary team of ophthalmologists, optometrists, and public health experts, the group conducts innovative clinical trials and observational studies aimed at understanding the progression of myopia and developing effective interventions. By leveraging advanced imaging technologies and longitudinal data collection, the group strives to enhance clinical practices and inform public health strategies to mitigate the impact of high myopia on visual health in the community.

Locations

Shanghai, Shanghai, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0